Genomics England

Britain must leverage its strengths to influence how artificial intelligence is deployed around the world, DeepMind founder Demis Hassabis said on Monday, as the AI research firm's owner Google announced upgrades to its offering in the country.

In a new study reported in Science Advances, scientists analyzed MRI data stored at the UK Biobank and identified seven genes responsible for fast biological brain aging and 13 existing drugs that can target those genes.

The arrival of big data, artificial intelligence (AI), and shared databases, offers unparallelled potential for advancing the study and treatment of rare diseases

UNC Charlotte researchers are contributing to pioneering breakthroughs in cancer therapeutics, communicable disease forecasting and prevention, optical applications for health care, and use of AI and other innovative computational tools — and more.

Speaking at DevSparks 2025, Gaurav Tripathi, Co-founder and chief technology officer of InnoPlexus, emphasised how AI-driven advancements in computational biology are enabling scientists to make discoveries at an unprecedented scale.

This new approach, powered by a specialised protein large language model, predicts the most effective protein variants while using 99% less data than traditional methods.

AI is already being tested in the NHS in a variety of ways, including helping to deliver cancer treatment, managing waiting lists and checking cancer scans. However, this is the biggest trial yet covering breast cancer.

AI-driven genomics startups leverage technology to analyze genetic data, predict predispositions, and offer personalized health recommendations.